TrialJAMA pediatrics2020

Familial Haploidentical Stem Cell Transplant in Children and Adolescents With High-Risk Sickle Cell Disease: A Phase 2 Clinical Trial.

Mitchell S Cairo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.